Economic Costs of Adverse Reactions to Drugs (ADRs) in Low and Middle-income Countries (LMICs)

被引:0
|
作者
Deoras, G. [1 ]
Iessa, N. [2 ]
Mantel-Teeuwisse, A. K. [1 ]
Pal, S. [2 ]
机构
[1] Univ Utrecht, Utrecht, Netherlands
[2] WHO, Geneva, Switzerland
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
P052
引用
收藏
页码:1016 / 1016
页数:1
相关论文
共 50 条
  • [1] The economic burden of dementia in low- and middle-income countries (LMICs): a systematic review
    Mattap, Siti Maisarah
    Mohan, Devi
    McGrattan, Andrea Mary
    Allotey, Pascale
    Stephan, Blossom C. M.
    Reidpath, Daniel D.
    Siervo, Mario
    Robinson, Louise
    Chaiyakunapruk, Nathorn
    [J]. BMJ GLOBAL HEALTH, 2022, 7 (04):
  • [2] Avian Influenza in Low and Middle-Income Countries (LMICs): Outbreaks, Vaccination Challenges and Economic Impact
    Subedi, Deepak
    Farhan, Muhammad Haris Raza
    Niraula, Abhisek
    Shrestha, Prajjwal
    Chandran, Deepak
    Acharya, Krishna Prasad
    Ahmad, Muhammad
    [J]. PAKISTAN VETERINARY JOURNAL, 2024, 44 (01) : 9 - 17
  • [3] Economic Costs of Childhood Lead Exposure in Low- and Middle-Income Countries
    Attina, Teresa M.
    Trasande, Leonardo
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2013, 121 (09) : 1097 - 1102
  • [4] Ten recommendations to improve pharmacy practice in low and middle-income countries (LMICs)
    Zaheer-Ud-Din Babar
    [J]. Journal of Pharmaceutical Policy and Practice, 14
  • [5] A glimpse of hope: cardiac surgery in low- and middle-income countries (LMICs)
    Zilla, Peter
    Bolman, R. Morton, III
    Boateng, Percy
    Sliwa, Karen
    [J]. CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2020, 10 (02) : 336 - 349
  • [6] The Role of ISoP in the Advancement of Pharmacovigilance in Low-and Middle-Income Countries (LMICs)
    Elhawary, Mohamed A.
    Ogar, Comfort K.
    Tarapues, Monica
    Caro, Angela
    Ndagije, Helen Byomire
    Benabdallah, Ghita
    Sefiani, Houda
    Rostom, Hadir
    [J]. DRUG SAFETY, 2023, 46 (12) : 1307 - 1312
  • [7] Editorial: Stigma and HIV Care in Low- and Middle-Income Countries (LMICs)
    Gesesew, Hailay Abrha
    Mwanri, Lillian
    Woldemichael, Kifle
    Ward, Paul
    [J]. FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [8] The Role of ISoP in the Advancement of Pharmacovigilance in Low-and Middle-Income Countries (LMICs)
    Mohamed A. Elhawary
    Comfort K. Ogar
    Mónica Tarapués
    Angela Caro
    Helen Byomire Ndagije
    Ghita Benabdallah
    Houda Sefiani
    Hadir Rostom
    [J]. Drug Safety, 2023, 46 : 1307 - 1312
  • [9] Ten recommendations to improve pharmacy practice in low and middle-income countries (LMICs)
    Babar, Zaheer-Ud-Din
    [J]. JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2021, 14 (01)
  • [10] Economic costs of childhood stunting to the private sector in low- and middle-income countries
    Akseer, Nadia
    Tasic, Hana
    Onah, Michael Nnachebe
    Wigle, Jannah
    Rajakumar, Ramraj
    Sanchez-Hernandez, Diana
    Akuoku, Jonathan
    Black, Robert E.
    Horta, Bernardo L.
    Nwuneli, Ndidi
    Shine, Ritta
    Wazny, Kerri
    Japra, Nikita
    Shekar, Meera
    Hoddinott, John
    [J]. ECLINICALMEDICINE, 2022, 45